SOLTA MEDICAL INC 4
4 · SOLTA MEDICAL INC · Filed Jan 27, 2014
Insider Transaction Report
Form 4
Holthe David
Director
Transactions
- Disposition from Tender
Common Stock
2014-01-23$2.92/sh−5,435,993$15,873,100→ 0 total(indirect: By LLC) - Disposition from Tender
Common Stock
2014-01-23$2.92/sh−96,501$281,783→ 0 total
Footnotes (2)
- [F1]Includes 34,782 shares deemed acquired pursuant to the grant of restricted stock units ("RSU's") on various dates. The vesting of the RSU's was accelerated in connection with the merger of the Issuer with Valeant Pharmaceuticals International, a Delaware corporation.
- [F2]Mr. Holthe is a managing director of Inlign CP III, LLC ("Inlign"). As such, Mr. Holthe may be deemed to share voting and dispositive power with regard to the shares held directly by Inlign. Mr. Holthe disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report will not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.